These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 17679618)

  • 1. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.
    Buys ES; Sips P; Vermeersch P; Raher MJ; Rogge E; Ichinose F; Dewerchin M; Bloch KD; Janssens S; Brouckaert P
    Cardiovasc Res; 2008 Jul; 79(1):179-86. PubMed ID: 18339647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired iNOS-sGC-cGMP signalling contributes to chronic hypoxic and hypercapnic pulmonary hypertension in rat.
    Xia XD; Xu ZJ; Hu XG; Wu CY; Dai YR; Yang L
    Cell Biochem Funct; 2012 Jun; 30(4):279-85. PubMed ID: 22290599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
    Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
    Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
    Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
    Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
    Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
    Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfhydryl-dependent dimerization of soluble guanylyl cyclase modulates the relaxation of porcine pulmonary arteries to nitric oxide.
    Ye L; Liu J; Liu H; Ying L; Dou D; Chen Z; Xu X; Raj JU; Gao Y
    Pflugers Arch; 2013 Feb; 465(2):333-41. PubMed ID: 23143201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
    Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
    Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
    Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
    Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.
    Nozik-Grayck E; Woods C; Taylor JM; Benninger RK; Johnson RD; Villegas LR; Stenmark KR; Harrison DG; Majka SM; Irwin D; Farrow KN
    Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(11):L868-76. PubMed ID: 25326578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
    De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells.
    Wen HC; Chuu CP; Chen CY; Shiah SG; Kung HJ; King KL; Su LC; Chang SC; Chang CH
    PLoS One; 2015; 10(4):e0125518. PubMed ID: 25928539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
    Lang M; Kojonazarov B; Tian X; Kalymbetov A; Weissmann N; Grimminger F; Kretschmer A; Stasch JP; Seeger W; Ghofrani HA; Schermuly RT
    PLoS One; 2012; 7(8):e43433. PubMed ID: 22912874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling.
    Dumitrascu R; Weissmann N; Ghofrani HA; Dony E; Beuerlein K; Schmidt H; Stasch JP; Gnoth MJ; Seeger W; Grimminger F; Schermuly RT
    Circulation; 2006 Jan; 113(2):286-95. PubMed ID: 16391154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
    Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
    Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation.
    Jernigan NL; Resta TC
    Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1366-75. PubMed ID: 12003794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.